The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus

Diabetologia

Volumn 44, Issue 8, 2001, Pages 929-945

  Pratley, R E ^a   Weyer, C ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Impaired glucose tolerance; Insulin action; Insulin secretion; Pathogenesis; Type II diabetes mellitus

Indexed keywords

GLUCOSE; INSULIN;

DIABETOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HIGH RISK PATIENT; HORMONE ACTION; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; GLUCOSE INTOLERANCE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; RISK FACTORS;

EID: 0034884627     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250100580     Document Type: Review

References (98)

1. Metabolic abnormalities in the development of type 2 diabetes mellitus
2. Lilly Lecture 1987. The triumvirate: B-cell, muscle liver. A collusion responsible for type 2 diabetes
3. Banting Lecture 1990. β-cells in type II diabetes mellitus
4. Insulin secretion in humans. Physiological regulation and alterations in disease states
5. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians
6. Diabetes mellitus in the Pima Indians: Incidence risk factors and pathogenesis
7. Kinetics of insulin secretion. Underlying metabolic events
8. Identification of the docked granule pool responsible for first-phase of glucose-stimulated insulin secretion
9. Glucose clamp technique: A method for quantifying insulin secretion and resistance
10. Aerobic exercise training-induced reductions in abdominal fat and glucose-stimulated insulin responses in middle-aged and older men
11. Aspects of the pathogenesis of type 2 diabetes
12. Risk factors for developing non-insulin dependent diabetes: A 10 year follow up of men in Uppsala
13. Fasting serum insulin concentration and early insulin response as risk determinants for developing diabetes
14. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents
15. Role of glucose and insulin resistance in development of type 2 diabetes mellitus; results of a 25-year follow-up study
16. Risk factors for type 2 diabetes in white population: Paris prospective study
17. Plasma insulin response among Nauruans: Prediction of deterioration in glucose tolerance over 6 yr.
18. Risk factors for worsening to diabetes in subjects with impaired glucose tolerance
19. A two-step model for development of non-insulin-dependent diabetes mellitus
20. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans
21. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies
22. Glucose kinetics and fatty acids in dogs on matched insulin infusion after glucose load
23. Loss of early phase of insulin release in humans impairs glucose tolerance and blunts thermic effect of glucose
24. Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans
25. Escape of hepatic glucose production during hyperglycemic glucose clamp
26. Interstitial insulin concentrations determine glucose uptake rates but not insulin resistance in lean and obese men
27. Biphasic insulin secretion during intravenous glucose tolerance test promotes optimal interstitial insulin profile
28. New concepts in extracellular signaling for insulin action: The single gateway hypothesis
29. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs
30. Quantification of the relationship between insulin sensitivity and beta-cell function in humans. Evidence for a hyperbolic function
31. Plasma insulin concentrations in nondiabetics and early diabetic subjects
32. Study of the relationship between glucose and insulin responses to an oral glucose load in man
33. Factors determining serum-insulin response in a population sample
34. The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus
35. Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests
36. Alterations in glucose metabolism in the elderly patient with diabetes
37. Relationship between glucose tolerance and glucose stimulated insulin response in 65-year-olds
38. Report of the expert committee on the diagnosis and classification of Diabetes mellitus
39. Impaired postprandial glucose utilization in non-insulin-dependent diabetes mellitus
40. Early metabolic defects in persons at increased risk for non-insulin dependent diabetes mellitus
41. Decreased sensitivity of the pancreatic beta cells to glucose in prediabetic and diabetic subjects. A glucose dose-response study
42. Analysis of early phase insulin responses in non-obese subjects with mild glucose intolerance
43. Insulin secretion and insulin deficiency in people with impaired glucose tolerance
44. Glucose tolerance, insulin secretion, and insulin sensitivity in non-obese and obese Japanese subjects
45. Relationship between heterogeneity of insulin responses and insulin resistance in normal subjects and patients with chemical diabetes
46. Relationship between glucose tolerance, insulin secretion, and insulin resistance in non-obese individuals with varying degrees of glucose tolerance
47. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus
48. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance
49. Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes
50. Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative
51. Peripheral tissue glucose uptake is not reduced after an oral glucose tolerance load in Southern Italian subjects at risk for developing non-insulin-dependent diabetes mellitus
52. Low acute insulin secretory responses in adult offspring of persons with early onset Type II diabetes
53. Abnormalities of B-cell function, insulin action and fat distribution in women with histories of gestational diabetes: Relationship to obesity
54. History of gestational diabetes leads to distinct metabolic alterations in non-diabetic African-American women with a parental history of type 2 diabetes
55. Congenital susceptibility to NIDDM. Role of intrauterine environment
56. Maternal diabetes during pregnancy: Consequences for the offspring
57. Impaired glucose tolerance in adolescent offspring of diabetic mothers. Relationship to fetal hyperinsulinism
58. Glucose tolerance and insulin secretion in children of mothers with pregestational IDDM or gestational diabetes
59. Insulin resistance and low early phase insulin secretion predict the progression from impaired glucose tolerance (IGT) to diabetes in Pima Indians
60. Evidence for an autosomal recessive gene regulating the persistence of the insulin response to glucose in man
61. Linkage analysis of acute insulin secretion with GLUT2 and glucokinase in Pima Indians and the identification of a missense mutation in GLUT2
62. Familiality of physical and metabolic characteristics that predict the development of non-insulin-dependent diabetes mellitus in Pima Indians
63. Insulin sensitivity and secretion in monozygotic and dizygotic twins
64. Exaggerated early insulin release and insulin resistance in a diabetes-prone population: A metabolic comparison of Pima Indians and Caucasians
65. Increased insulin resistance and insulin secretion in non-diabetic African-Americans and Hispanics compared with non-Hispanic whites: The Insulin Resistance in Atherosclerosis Study
66. Familial hyperglycemia due to mutations in glucokinase: Definition of a new subtype of non-insulin-dependent (type 2) diabetes mellitus
67. Mutations in the hepatocyte nuclear factor-1-alpha gene in maturity onset diabetes of the young (MODY3)
68. Mutations in the hepatocyte nuclear factor-4-alpha gene in maturity onset diabetes of the young (MODY1)
69. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1
70. The diabetic intrauterine milieu has a long-lasting effect on insulin secretion by B cells and on insulin uptake by target tissues
71. Deterioration in carbohydrate metabolism and lipoprotein metabolism induced by a modern, high fat diet in Pima Indians and Caucasians
72. Reduced beta-cell compensation to the insulin resistance associated with obesity in members of caucasian familial type 2 diabetic kindreds
73. Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians
74. Visceral adipose tissue is not increased in Pima Indians compared with equally obese Caucasians and is not related to insulin action or secretion
75. Long-term changes in insulin action and insulin secretion associated with gain, loss, regain and maintenance of body weight
76. Fatty acids, lipotoxicity and insulin secretion
77. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications
78. Disordered metabolism in diabetes: Have we underestimated the fat component?
79. Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects
80. Lowering fatty acids potentiates acute insulin response in first degree relatives of people with type II diabetes
81. Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion: A study in normal rats using chronic in vivo glucose infusions
82. Overnight inhibition of insulin secretion restores pulsatility and proinsulin/insulin ratio in type 2 diabetes
83. Diet-induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus
84. Normalization of insulin and glucagon secretion in ketosis-resistant diabetes mellitus with prolonged diet therapy
85. Effect of chronic hyperglycemia on insulin secretion in partially pancreatectomized rats
86. Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes
87. Restoration of early rise in plasma insulin levels improves the glucose tolerance in type 2 diabetic patients
88. Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer
89. Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3 week period in patients with early type 2 diabetes
90. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM
91. Differential effects of tolbutamide on first and second phase insulin secretion in noninsulin-dependent diabetes mellitus
92. Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects
93. Influence of gliclazide on glucose-stimulated insulin release in man
94. Effect of sulfonylurea on glucose-stimulated insulin secretion in healthy and non-insulin dependent diabetic subjects: A dose-response study
95. Effect of glibenclamide on insulin release at moderate and high blood glucose levels in normal man
96. Increased prandial insulin secretion after administration of a single preprandial oral dose of repaglinide in patients with type 2 diabetes
97. Effects of the new oral hypoglycaemic agent nateglinide on insulin secretion in type 2 diabetes mellitus
98. Rapid and short acting mealtime insulin secretion with nateglinide controls both prandial and mean glycemia